Table 2.

General data, Lp-PLA₂ and IMA of cognitive impairment and normal cognitive function groups.

	Cognitive impairment group (n = 18)	Normal cognitive function group (n = 102)	t/$\chi$2	p
Gender (male/female)	9/9	59/43	0.383	0.536
Age (year)	56.78 $\pm$ 6.43	56.99 $\pm$ 6.52	0.126	0.900
BMI (kg/m2)	23.41 $\pm$ 2.97	23.50 $\pm$ 2.86	0.122	0.903
Hypertension (Yes/No)	11/7	30/72	6.835	0.009
Coronary heart disease (Yes/No)	13/5	28/74	13.635	0.001
Family history of stroke (Yes/No)	15/3	12/90	44.942	0.001
Smoking and drinking history (Yes/No)	16/2	31/67	20.685	0.001
FBG (mmol/L)	8.65 $\pm$ 0.43	6.12 $\pm$ 0.74	14.060	0.001
TC (mmol/L)	5.64 $\pm$ 0.74	4.00 $\pm$ 0.32	15.720	0.001
Duration from onset to admission (h)	6.34 $\pm$ 0.53	4.24 $\pm$ 0.65	12.950	0.001
NIHSS at admission (point)	11.97 $\pm$ 1.08	8.01 $\pm$ 0.78	18.660	0.001
Lp-PLA2 (µg/L)	261.96 $\pm$ 25.89	68.77 $\pm$ 7.92	61.650	0.001
IMA (U/mL)	123.54 $\pm$ 13.67	78.65 $\pm$ 9.31	17.460	0.001

Lp-PLA₂, lipoprotein-associated phospholipase A₂; IMA, ischemia-modified albumin; BMI, body mass index; FBG, fasting blood glucose; TC, total cholesterol.